WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 10 fonti

Novel Hep B Drug Delivers Functional Cures in Late-Stage Trials

Findings 'will change the landscape' of treatment, researcher says

Raccontata da

biopharmadive.com

independent.co.uk

economictimes.indiatimes.com

morningstar.com

medpagetoday.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo9 h fa

Novel Hep B Drug Delivers Functional Cures in Late-Stage Trials

Findings 'will change the landscape' of treatment, researcher says

economictimes.indiatimes.com

Timeline cronologica

giovedì 28 maggio 2026·biopharmadive.com
GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’
The findings supporting bepirovirsen were deemed a “historic moment” by physicians and validate a drug that has “clear blockbuster potential,” according to one analyst.
giovedì 28 maggio 2026·apnews.com
Experimental hepatitis B drug may offer 'functional cure' for some patients
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus.

13 h fa

GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies

GSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achieving a functional cure after six months of treatment. This offers a potential…

Leggi questa versione → originale

biopharmadive.com22 h fa

GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’

The findings supporting bepirovirsen were deemed a “historic moment” by physicians and validate a drug that has “clear blockbuster potential,” according to one analyst.

Leggi questa versione → originale

Hepatitis B drug may offer 'functional cure' for some patients

Researchers reported Thursday that in two international studies, about 1 in 5 patients given the experimental drug for six months saw their virus reduced to levels low enough that the immune system could keep it in…

Leggi questa versione → originale

independent.co.uk12 h fa

FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

Leggi questa versione → originale

statnews.com13 h fa

Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show

An experimental GSK drug helped 1 in 5 patients with chronic hepatitis B achieve what's known as a functional cure, vastly outpacing current treatments.

Leggi questa versione → originale

giovedì 28 maggio 2026·

statnews.com

Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show

An experimental GSK drug helped 1 in 5 patients with chronic hepatitis B achieve what's known as a functional cure, vastly outpacing current treatments.

giovedì 28 maggio 2026·

independent.co.uk

Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

giovedì 28 maggio 2026·

endpoints.news

GSK's functional cure data for hepatitis B drug are a major leap over standard of care

GSK has shared detailed results from a pair of late-stage trials testing a chronic hepatitis B treatment originally developed by Ionis Pharmaceuticals, with regulatory reviews…

giovedì 28 maggio 2026·

economictimes.indiatimes.com

GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies

GSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achieving a functional cure after six months of…

giovedì 28 maggio 2026·

morningstar.com

Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic…

Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B

giovedì 28 maggio 2026·

independent.co.uk

FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

giovedì 28 maggio 2026·

cnn.com

Experimental hepatitis B drug might offer ‘functional cure’ for a subset of patients | CNN

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers…

giovedì 28 maggio 2026·

medpagetoday.com

Novel Hep B Drug Delivers Functional Cures in Late-Stage Trials

Findings 'will change the landscape' of treatment, researcher says

giovedì 28 maggio 2026·

pbs.org

Hepatitis B drug may offer 'functional cure' for some patients

Researchers reported Thursday that in two international studies, about 1 in 5 patients given the experimental drug for six months saw their virus reduced to levels low enough that…